Approvals/NMPA/Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation

Approved

化学药品

Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation

GLAXOSMITHKLINE (IRELAND) LIMITED🇨🇳 National Medical Products Administration

Approval Id: 64215b4618ea12e3
Approval Number: 国药准字HJ20180005
Generic Name: 乌美溴铵维兰特罗吸入粉雾剂
Generic Name En: Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation
Trade Name: 欧乐欣
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 每泡含乌美溴铵62.5μg（按C₂₉H₃₄NO₂计）与三苯乙酸维兰特罗25μg（按C₂₄H₃₃Cl₂NO₅计），递送剂量为乌美溴铵55µg（按C₂₉H₃₄NO₂计）与三苯乙酸维兰特罗22µg（按C₂₄H₃₃Cl₂NO₅计）。
Reg Date: 2023-01-04
Expired Date: 2028-01-03
Company Name: GLAXOSMITHKLINE (IRELAND) LIMITED
Production Company Name: Glaxo Operations UK Ltd.
Company Detail Path: /organization/glaxosmithkline-ireland-limited
Production Company Detail Path: /organization/glaxo-operations-uk-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 4, 2023

Approval ID

64215b4618ea12e3

Type

化学药品